Eunchong Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Eunchong Kim has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- In Seok Jeong
Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea
2 shared publications - Ju Sik Yun
Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hwasun Hospital, Chonnam National University Medical School , Hwasun-eup, Jeollanam-do 58128
2 shared publications - Kook Joo Na
Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hwasun Hospital, Chonnam National University School of Medicine, Hwasun, Korea
2 shared publications - Sang Yun Song
Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hwasun Hospital, Chonnam National University School of Medicine, Hwasun, Korea
2 shared publications - Do Wan Kim
Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea
1 shared publication - Hwa Jin Cho
Chonnam National University Children’s Hospital and Medical School
1 shared publication
Latest Publications
- Open Access
- 2 March 2022
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 55 (2) , 143-150
Prediction of 6-Month Mortality Using Pre-Extracorporeal Membrane Oxygenation Lactate in Patients with Acute Coronary Syndrome Undergoing Veno-Arterial-Extracorporeal Membrane Oxygenation
Eunchong Kim, M.D., Nodirbek Yuldashev Sodirzhon-Ugli, M.D., Do Wan Kim, M.D., Kyo Seon Lee, M.D., Yonghwan Lim, M.D., Min-Chul Kim, M.D., Ph.D., Yong Soo Cho, M.D., Yong Hun Jung, M.D., Ph.D., Kyung Woon Jeung, M.D., Ph.D., Hwa Jin Cho, M.D., Ph.D., In Seok Jeong, M.D., Ph.D.. J Chest Surg 2022;55:143-50. https://doi.org/10.5090/jcs.21.127
- 2 March 2022
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 55 (2) , 143-150
Open AccessPrediction of 6-Month Mortality Using Pre-Extracorporeal Membrane Oxygenation Lactate in Patients with Acute Coronary Syndrome Undergoing Veno-Arterial-Extracorporeal Membrane Oxygenation
Eunchong Kim, M.D., Nodirbek Yuldashev Sodirzhon-Ugli, M.D., Do Wan Kim, M.D., Kyo Seon Lee, M.D., Yonghwan Lim, M.D., Min-Chul Kim, M.D., Ph.D., Yong Soo Cho, M.D., Yong Hun Jung, M.D., Ph.D., Kyung Woon Jeung, M.D., Ph.D., Hwa Jin Cho, M.D., Ph.D., In Seok Jeong, M.D., Ph.D.. J Chest Surg 2022;55:143-50. https://doi.org/10.5090/jcs.21.127
- Open Access
- 5 February 2022
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 55 (1) , 88-90
Successful Surgical Management of a Tracheo-Innominate Artery Fistula in a Patient with Duchenne Muscular Dystrophy: A Case Report
Ju Sik Yun, M.D., Sang Yun Song, M.D., Ph.D., Kook Joo Na, M.D., Ph.D., Eunchong Kim, M.D.. J Chest Surg -0001;0:. https://doi.org/10.5090/jcs.21.121
- 5 February 2022
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 55 (1) , 88-90
Open AccessSuccessful Surgical Management of a Tracheo-Innominate Artery Fistula in a Patient with Duchenne Muscular Dystrophy: A Case Report
Ju Sik Yun, M.D., Sang Yun Song, M.D., Ph.D., Kook Joo Na, M.D., Ph.D., Eunchong Kim, M.D.. J Chest Surg -0001;0:. https://doi.org/10.5090/jcs.21.121
- Open Access
- 29 August 2021
- Published by Wiley in Thoracic Cancer
- Vol. 12 (19) , 2537-2543
Thoracoscopic pulmonary metastasectomy in metastatic colorectal cancer: Surgical outcomes and prognostic factors
Background: This study aimed to confirm the effectiveness of thoracoscopic metastasectomy for colorectal cancer (CRC) and determine its prognostic factors.Methods: Of the 181 patients who underwent video‐assisted thoracoscopic surgery (VATS) for pulmonary metastases from CRC between 2011 and 2017, 173 were retrospectively reviewed. Surgical outcomes, long‐term survival, and the factors affecting the prognosis were analyzed.Results: The patients in the study were predominantly male (n = 104, 60.1%), and the median age was 65 years (range, 25–83 years). The median follow‐up time was 46 months (range, 0–114 months). The surgical procedures were 156 wedge resections, five segmentectomies, and 12 lobectomies. Conversion to thoracotomy was required in nine patients. The postoperative complication rate was 2.9%, and the in‐hospital mortality rate was 1.2%. The overall 1‐, 3‐, and 5‐year survival rates were 94.8%, 70.6%, and 51.8%, respectively. Univariate analysis showed that the prognostic factors for survival were age (p = 0.027), pathological stage of CRC (p = 0.019), prior extrathoracic metastasis (p = 0.005), preoperative carcinoembryonic antigen level (p = 0.020), number of pulmonary metastases (p = 0.011), and disease‐free interval (p = 0.026). In the multivariate analysis, two factors were related to prognosis: age (hazard ratio [HR], 1.881; 95% confidence interval [CI]; 1.189–2.976; p = 0.007) and prior extrathoracic metastasis (HR, 2.170; 95% CI; 1.269–3.711; p = 0.005).Conclusions: VATS for pulmonary metastasectomy for CRC can be performed relatively safely, and our results regarding long‐term survival are comparable with those of other studies. In this study, older age (≥70 years) and prior extrathoracic metastasis were independent prognostic factors of poor prognosis.
- 29 August 2021
- Published by Wiley in Thoracic Cancer
- Vol. 12 (19) , 2537-2543
Open AccessThoracoscopic pulmonary metastasectomy in metastatic colorectal cancer: Surgical outcomes and prognostic factors
Background: This study aimed to confirm the effectiveness of thoracoscopic metastasectomy for colorectal cancer (CRC) and determine its prognostic factors.Methods: Of the 181 patients who underwent video‐assisted thoracoscopic surgery (VATS) for pulmonary metastases from CRC between 2011 and 2017, 173 were retrospectively reviewed. Surgical outcomes, long‐term survival, and the factors affecting the prognosis were analyzed.Results: The patients in the study were predominantly male (n = 104, 60.1%), and the median age was 65 years (range, 25–83 years). The median follow‐up time was 46 months (range, 0–114 months). The surgical procedures were 156 wedge resections, five segmentectomies, and 12 lobectomies. Conversion to thoracotomy was required in nine patients. The postoperative complication rate was 2.9%, and the in‐hospital mortality rate was 1.2%. The overall 1‐, 3‐, and 5‐year survival rates were 94.8%, 70.6%, and 51.8%, respectively. Univariate analysis showed that the prognostic factors for survival were age (p = 0.027), pathological stage of CRC (p = 0.019), prior extrathoracic metastasis (p = 0.005), preoperative carcinoembryonic antigen level (p = 0.020), number of pulmonary metastases (p = 0.011), and disease‐free interval (p = 0.026). In the multivariate analysis, two factors were related to prognosis: age (hazard ratio [HR], 1.881; 95% confidence interval [CI]; 1.189–2.976; p = 0.007) and prior extrathoracic metastasis (HR, 2.170; 95% CI; 1.269–3.711; p = 0.005).Conclusions: VATS for pulmonary metastasectomy for CRC can be performed relatively safely, and our results regarding long‐term survival are comparable with those of other studies. In this study, older age (≥70 years) and prior extrathoracic metastasis were independent prognostic factors of poor prognosis.